Triglyceride accumulation in adipocyte

Triglyceride accumulation in adipocytes refers to the cellular process where excess energy—primarily from dietary carbohydrates and fats—is stored within specialized cells called adipocytes as triglycerides. This occurs through coordinated uptake of glucose and fatty acids followed by their conversion into triglycerides via enzymatic pathways involving glycerol backbone formation and fatty acid esterification. The resulting lipid droplets occupy most of the cell’s volume. This mechanism allows for efficient long-term energy storage during periods of caloric surplus while protecting other organs from toxic effects associated with ectopic lipid buildup. Dysregulation leads to metabolic diseases including obesity, type 2 diabetes mellitus, cardiovascular disease risk factors due to altered systemic metabolism; conversely, failure results in conditions like lipodystrophy with severe metabolic consequences.[1][2][3]

Other names

Triglyceride storage in adipocyteFat accumulation in adipocyteLipid droplet formation (in context)Adipocyte triglyceride deposition

Drugs that affect triglyceride accumulation typically act by: - Modulating insulin sensitivity to alter glucose uptake and fatty acid esterification[1][2] - Inhibiting or stimulating enzymes such as diacylglycerol acyltransferase for triglyceride synthesis[2] - Influencing hormone-sensitive lipase activity for lipolysis